These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 33004987)
1. Untargeted longitudinal analysis of a wellness cohort identifies markers of metastatic cancer years prior to diagnosis. Magis AT; Rappaport N; Conomos MP; Omenn GS; Lovejoy JC; Hood L; Price ND Sci Rep; 2020 Oct; 10(1):16275. PubMed ID: 33004987 [TBL] [Abstract][Full Text] [Related]
2. Persistent elevation of carcinoembryonic antigen as first presentation of a medullary thyroid carcinoma. Martins A; Gonçalves A; Almeida T; Midões A BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29895542 [TBL] [Abstract][Full Text] [Related]
3. Five Patients with Medullary Thyroid Carcinoma Presenting as Asymptomatic Elevation of Carcinoembryonic Antigen Level. Tan KT; Tan JZ Ann Acad Med Singap; 2015 Jun; 44(6):226-8. PubMed ID: 26292951 [No Abstract] [Full Text] [Related]
4. Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer. Turkdogan S; Forest VI; Hier MP; Tamilia M; Florea A; Payne RJ J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):55. PubMed ID: 30223887 [TBL] [Abstract][Full Text] [Related]
5. Biomarkers of medullary thyroid cancer in the prediction of cure after thyroidectomy. Nien FJ; Chang TC J Formos Med Assoc; 2015 Sep; 114(9):793-4. PubMed ID: 23906686 [No Abstract] [Full Text] [Related]
6. The Levels of Tumor Markers in Pancreatic Neuroendocrine Carcinoma and Their Values in Differentiation Between Pancreatic Neuroendocrine Carcinoma and Pancreatic Ductal Adenocarcinoma. Zhuge X; Guo C; Chen Y; Feng L; Jia R; Zhao Y; Sun K; Wang Z; Chen X Pancreas; 2018; 47(10):1290-1295. PubMed ID: 30308534 [TBL] [Abstract][Full Text] [Related]
7. Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis. Xu CH; Wang Y; Qian LH; Yu LK; Zhang XW; Wang QB Clin Respir J; 2017 Nov; 11(6):765-771. PubMed ID: 26605871 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen. Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679 [TBL] [Abstract][Full Text] [Related]
9. Chronic diarrhea: The first symptom of a metastatic medullary thyroid carcinoma. Ernaga Lorea A; Migueliz Bermejo I; Eguílaz Esparza N; Hernández Morhain MC; Pineda Arribas J Gastroenterol Hepatol; 2018 Feb; 41(2):105-107. PubMed ID: 28259364 [No Abstract] [Full Text] [Related]
10. Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer. Yang Y; Pospisil P; Iyer LK; Adelstein SJ; Kassis AI PLoS One; 2008; 3(11):e3661. PubMed ID: 18987750 [TBL] [Abstract][Full Text] [Related]
11. High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer. Chen SW; Chen YK World J Surg Oncol; 2017 Dec; 15(1):230. PubMed ID: 29284496 [TBL] [Abstract][Full Text] [Related]
12. Baseline and stimulated calcitonin: Thresholds for the diagnosis of medullary thyroid cancer. Fugazzola L Ann Endocrinol (Paris); 2019 Jun; 80(3):191-192. PubMed ID: 31053250 [No Abstract] [Full Text] [Related]
13. Utilizing the circulating tumor markers in diagnosis and management of medullary thyroid cancer. Zarkesh M; Arab N; Tavangar SM; Nozhat Z; Fanaei SM; Hedayati M Pathol Res Pract; 2022 Jan; 229():153694. PubMed ID: 34929598 [TBL] [Abstract][Full Text] [Related]
14. Lack of Association between Serum Adiponectin/Leptin Levels and Medullary Thyroid Cancer. Abooshahab R; Yaghmaei P; Ghadaksaz HG; Hedayati M Asian Pac J Cancer Prev; 2016; 17(8):3861-4. PubMed ID: 27644630 [TBL] [Abstract][Full Text] [Related]
15. Thresholds of Basal- and Calcium-Stimulated Calcitonin for Diagnosis of Thyroid Malignancy. Băetu M; Olariu CA; Stancu C; Caragheorgheopol A; Ioachim D; Moldoveanu G; Corneci C; Badiu C Horm Metab Res; 2021 Dec; 53(12):779-786. PubMed ID: 34687025 [TBL] [Abstract][Full Text] [Related]
16. A bead-based multiplexed immunoassay to evaluate breast cancer biomarkers for early detection in pre-diagnostic serum. Opstal-van Winden AW; Rodenburg W; Pennings JL; van Oostrom CT; Beijnen JH; Peeters PH; van Gils CH; de Vries A Int J Mol Sci; 2012 Oct; 13(10):13587-604. PubMed ID: 23202969 [TBL] [Abstract][Full Text] [Related]
18. Carcino-embryonic antigen--no help with the differential diagnosis. Cobben-Beld EG; Nortier JW; Kramer WL; van de Wiel A; Rodenburg CJ Neth J Med; 1996 Mar; 48(3):96-9. PubMed ID: 8935750 [TBL] [Abstract][Full Text] [Related]
19. Age-stratified and gender-specific reference intervals of six tumor markers panel of lung cancer: A geographic-based multicenter study in China. Li Y; Li M; Zhang Y; Zhou J; Jiang L; Yang C; Li G; Qu W; Li X; Chen Y; Chen Q; Wang W; Wang S; Liang Xing J; Huang H J Clin Lab Anal; 2021 Jun; 35(6):e23816. PubMed ID: 33982344 [TBL] [Abstract][Full Text] [Related]
20. THE COMBINED USE OF CALCITONIN DOUBLING TIME AND Yang JH; Camacho CP; Lindsey SC; Valente FOF; Andreoni DM; Yamaga LY; Wagner J; Biscolla RPM; Maciel RMB Endocr Pract; 2017 Aug; 23(8):942-948. PubMed ID: 28614009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]